Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
January 2011
January 2011
NCT00626548Uploaded 08-04-2014
Available for Download
PDS UID: Prostat_AstraZe_2008_103
A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 (Zibotentan) 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients
PDS UID: Prostat_Multipl_2008_406Go to Study
Enhancing the Analytic Capacity of Prostat_AstraZe_2008_103 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLZibotentan CSP D4320C00015 With Redactions_Redacted.pdf
CRFNot Provided
DATA DICTIONARYRDB Standards - D4320C00015 and D4320C00033.xlsx
DATA (COMPARATOR ARM)D4320C00015 De-Identified RDB Data.zip